Filing Details

Accession Number:
0001209191-15-031615
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-04-02 17:11:25
Reporting Period:
2015-03-25
Filing Date:
2015-04-02
Accepted Time:
2015-04-02 17:11:25
Original Submission Date:
2015-04-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Oncothyreon Inc. ONTY Services-Commercial Physical & Biological Research (8731) 260868560
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238403 K Daniel Spiegelman C/O Oncothyreon Inc.
2601 Fourth Ave., Suite 500
Seattle WA 98121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-25 10,000 $1.63 30,644 No 4 P Direct
Common Stock Acquisiton 2015-03-26 10,000 $1.59 40,644 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the aggregate of sales effected on the same day at different prices.
  2. As the result of a broker administrative error, the Form 4 previously filed with the U.S. Securities and Exchange Commission (the "SEC") incorrectly reported one purchase price for the aggregate of shares purchased. The purchase price is corrected on this amended Form 4. The amended purchase price represents the weighted average purchase price per share. The shares were purchased at prices ranging from $1.62 to $1.63 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
  3. As the result of a broker administrative error, the Form 4 previously filed with the SEC incorrectly reported one purchase price for the aggregate of shares purchased. The purchase price is corrected on this amended Form 4. The amended purchase price represents the weighted average purchase price per share. The shares were purchased at prices ranging from $1.58 to $1.59 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.